A new drug that specifically targets cancer cells has shown promising results in phase three clinical trials. A genetically-modified herpes virus injected into […]
Continue readingimmune reaction
ODT: Rat study links maternal illness to schizophrenia risk
Eileen Goodwin writes in the Otago Daily Times about research from the University of Otago showing that flu jabs and […]
Continue reading